About/Juvenile Diabetes Research Foundation/Seattle/Researching Type 1 Diabetes
Type 1 diabetes in children used to be known as juvenile diabetes or insulin-dependent diabetes. Alternative Names of T1D: Insulin-dependent diabetes; Juvenile onset diabetes; Diabetes – type 1. Type 1 Diabetes – In type 1 diabetes, your immune system mistakenly destroys the cells in your pancreas that make insulin. Your body treats these cells as invaders and destroys them. This can happen over a few weeks, months, or years. When enough beta cells are destroyed, your pancreas stops making insulin, or makes too little insulin. Because the pancreas does not make insulin, insulin needs to be replaced. Insulin does not come in a pill. People with type 1 diabetes take insulin by injection with a syringe, an insulin pen, or an insulin pump. Without insulin, your blood glucose rises and is higher than normal, which is called hyperglycemia. Type 1 diabetes affects about 5% of people in the United States with diabetes. In the past type 1 diabetes was called juvenile diabetes or insulin-dependent diabetes. It’s usually first diagnosed in young people but it can occur at any age. Type 1 diabetes is much less common than type 2 diabetes. JDRF’s research goal is to discover, develop, and deliver advances that progressively remove the impact of T1D from people’s lives until we find a cure. JDRF is driving research across the entire scientific spectrum, from discovery in the laboratory to delivery of new technologies and treatments to people with T1D.
The full impact of JDRF’s research investment extends well beyond our direct funding. Now more than ever, we see the value in leveraging partnerships with academia, industry and clinicians to ensure that the most promising research opportunities are funded and accelerated. JDRF often provides early-stage funding to research projects, and the results of those projects often lead to follow-on participation from many other entities – both other not-for-profit funders and corporations. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services List of all video credits is located here http://broadcaster.beazil.net/public/credits/youtube/videos/41421 City of Flowers, Coffee Capital of the World, Jet City, Queen City or simply Seattle is a West Coast seaport city and the seat of King County. With an estimated 684,451 residents as of 2015, Seattle is the largest city in both the state of Washington and the Pacific Northwest region of North America. In July 2013 it was the fastest-growing major city in the United States, and remained in the top five in May 2015 with an annual growth rate of 2.1%. The Seattle metropolitan area of around 3.7 million inhabitants is the 15th largest metropolitan area in the United States. The city is situated on an isthmus between Puget Sound (an inlet of the Pacific Ocean) and Lake Washington, about 100 miles (160 km) south of the Canada–United States border. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To conclude, the main issues should be pointed out –
T1D management,Hypoglycemia Prevention,Beta Cell Health and Survival,DPP,T1D,become a volunteer,2-h PG value,2-h plasma glucose value,High Blood Sugar,A1C complications,no insulin production,diabetes mellitus,TypeOneNation,alpha-glucosidase inhibitor,Kussmaul breathing,Managing a hypo,insulin glargine,Ride to Cure Diabetes,Greater Louisville Walk,MODY,Incretin-Based Therapies,ADA,Glucose Modulating Agents,Children’s Congress,glycemic control comparison,SDP,rapid insulin injection,Retinopathy,patient self-monitoring of blood glucose,The Promise Campaign,Biomarkers and Imaging,Pancreas,PIs,CONCEPTT,Diabetes Care,T1DLooksLikeMe,secondary diabetes,donate today,Artificial Pancreas Project,Roche Diabetes Care,American Diabetes Association,T1D community,Premixed insulin,T1D Mentors,T1D Care Kit,contribution,Heart.